Torsade de Pointes Tachycardia in a Patient on Dronedarone Therapy

2015 ◽  
Vol 35 (5) ◽  
pp. e61-e65 ◽  
Author(s):  
Martin Huemer ◽  
Giselle Sarganas ◽  
Elisabeth Bronder ◽  
Andreas Klimpel ◽  
Edeltraut Garbe ◽  
...  
Keyword(s):  
Torsade De Pointes ◽  
Torsade De Pointes Tachycardia

Cardiac arrhythmias related to psychiatric medication

2017 ◽  
Vol 36 (09) ◽  
pp. 747-750
Author(s):  
R. W. Freudenmann ◽  
C. Schönfeldt-Lecuona ◽  
B. J. Connemann ◽  
M. Gahr ◽  
M. Elsayed
Keyword(s):  
Cardiac Arrhythmias ◽  
Torsade De Pointes ◽  
General Medicine ◽  
Fold Increase ◽  
Cardiac Risk ◽  
Psychiatric Medication ◽  
Cardiac Side Effects ◽  
Torsade De Pointes Tachycardia ◽  
Multiple Drugs ◽  
Available Information

SummaryThis narrative review summarizes current available information about cardiac arrhythmias (QT prolongation, Torsade de pointes Tachycardia [TdP], sudden cardiac death) associated with psychiatric medication. Among the most commonly used antipsychotics, amisulpride and ziprasidone are most frequently associated with TdP. Treatment with some antidepressants (SSRIs, tricyclic antidepressants) is associated with a 5- to 6-fold increase in the incidence of out-of-hospital cardiac arrest. Lithium is associated with bradycardia, T-wave changes and AV-block; anxiolytics of the benzodiazepine group do usually not have cardiac side effects. The combination of multiple drugs (including medications from general medicine) that prolong the QT interval has a particularly high cardiac risk.

Doxepin-Induced Torsade de Pointes Tachycardia

2001 ◽  
Vol 135 (5) ◽  
pp. 384 ◽  
Author(s):  
Peter Alter ◽  
Daniela Tontsch ◽  
Wolfram Grimm
Keyword(s):  
Torsade De Pointes ◽  
Torsade De Pointes Tachycardia

scholarly journals Epiglottitis and torsade de pointes tachycardia.

Heart ◽  
1994 ◽  
Vol 72 (2) ◽  
pp. 205-208 ◽  
Author(s):  
C M Pripp ◽  
P Blomstrom
Keyword(s):  
Torsade De Pointes ◽  
Torsade De Pointes Tachycardia

scholarly journals "Torsade de pointes" tachycardia. Re-entry or focal activity?

Heart ◽  
1982 ◽  
Vol 48 (3) ◽  
pp. 213-216 ◽  
Author(s):  
C N D'Alnoncourt ◽  
W Zierhut ◽  
B Bluderitz
Keyword(s):  
Torsade De Pointes ◽  
Torsade De Pointes Tachycardia

A presumably benign human ether-a-go-go-related gene mutation (R176W) with a malignant primary manifestation of long QT syndrome

2011 ◽  
Vol 22 (3) ◽  
pp. 360-363 ◽  
Author(s):  
Birgit C. Donner ◽  
Christoph Marshall ◽  
Klaus G. Schmidt
Keyword(s):  
Long Qt Syndrome ◽  
Qt Interval ◽  
Clinical Phenotype ◽  
Torsade De Pointes ◽  
Holter Monitoring ◽  
Related Gene ◽  
Long Qt ◽  
Torsade De Pointes Tachycardia ◽  
Qt Syndrome ◽  
Mild Clinical Phenotype

AbstractA 12-year-old girl presented with a first prolonged syncope. She was successfully resuscitated by external defibrillation after recording torsade de pointes tachycardia. Repeated electrocardiograms and a 12-channel Holter monitoring showed an intermittent prolongation of the QT interval. Genetic analysis identified a heterozygous point mutation in the KCNH2 gene, which is thought to be associated with a rather mild clinical phenotype of the long QT syndrome.

EKG-gyöngyszem: szerzett hosszú-QT-szindróma

2018 ◽  
Vol 159 (39) ◽  
pp. 1607-1610 ◽  
Author(s):  
János Tomcsányi ◽  
Kristóf Tomcsányi
Keyword(s):  
Long Qt Syndrome ◽  
Torsade De Pointes ◽  
Long Qt ◽  
Drug Induced ◽  
Torsade De Pointes Tachycardia ◽  
Qt Syndrome

Abstract: Authors report the case of a patient with drug-induced long QT syndrome. This case highlights the importance of ECG signs of LQTS that may lead to torsade de pointes tachycardia. The patient received the QT prolonging moxifloxacine and the QT remained long even after the offending drug was discontinued. Orv Hetil. 2018; 159(39): 1607–1610.

Sign in / Sign up

Export Citation Format

Share Document